| manufacturer_name | ndc_number | drug_product_description | date_introduced_to_market | wac_at_introduction | marketing_pricing_plan_description | marketing_pricing_plan_non_public_indicator | estimated_number_of_patients | breakthrough_therapy_indicator | priority_review_indicator | acquisition_date | acquisition_price | acquisition_price_non_public_indicator | acquisition_price_comment | general_comments | supporting_documents |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| QOL Medical LLC | 67871011107 | Sucraid (Sacrosidase) Oral Solution 8500IU/mL, 6ct, 2mL Vials | 2022-09-13 | 10535.0000 | None | 1 | 2000 | None | None | None | None | None | None | QOL anticipates the first shipments of this product in the next few weeks. | None |